Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Sim

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout miceJennifer A Loehle, Valerie Cornish, Larissa Wakefield, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs)Edward W Brooke, Stephen G Davies, Andrew W Mulvaney, et al.
Plos One|May 15, 2014
From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2Nicola Laurieri, Julien Dairou, James E Egleton, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 20, 2003
Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferaseFernando Rodrigues-Lima, Racquel N Cooper, Bertrand Goudeau, et al.
Breast Cancer Research : BCR|February 16, 2012
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarkerIda Johansson, Cecilia Nilsson, Pontus Berglund, et al.
Journal of the American Chemical Society|February 23, 2010
Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarkerNicola Laurieri, Matthew H J Crawford, Akane Kawamura, et al.
Bioorganic & Medicinal Chemistry|March 21, 2007
Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutarisVukani Eliya Madikane, Sanjib Bhakta, Angela J Russell, et al.
Anti-Cancer Drugs|November 29, 2007
Synthesis and anticancer activities of 6-amino amonafide derivativesJohn T Norton, Mark A Witschi, Lynn Luong, et al.
Molecular Reproduction and Development|December 29, 2007
Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockoutsRobert P Erickson, Wen Cao, Diana K Acuña, et al.
Bioorganic & Medicinal Chemistry|December 9, 2008
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2Angela J Russell, Isaac M Westwood, Matthew H J Crawford, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2006
N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout miceJennifer A Loehle, Valerie Cornish, Larissa Wakefield, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs)Edward W Brooke, Stephen G Davies, Andrew W Mulvaney, et al.
Plos One|May 15, 2014
From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2Nicola Laurieri, Julien Dairou, James E Egleton, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 20, 2003
Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferaseFernando Rodrigues-Lima, Racquel N Cooper, Bertrand Goudeau, et al.
Breast Cancer Research : BCR|February 16, 2012
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarkerIda Johansson, Cecilia Nilsson, Pontus Berglund, et al.
Journal of the American Chemical Society|February 23, 2010
Small molecule colorimetric probes for specific detection of human arylamine N-acetyltransferase 1, a potential breast cancer biomarkerNicola Laurieri, Matthew H J Crawford, Akane Kawamura, et al.
Bioorganic & Medicinal Chemistry|March 21, 2007
Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutarisVukani Eliya Madikane, Sanjib Bhakta, Angela J Russell, et al.
Anti-Cancer Drugs|November 29, 2007
Synthesis and anticancer activities of 6-amino amonafide derivativesJohn T Norton, Mark A Witschi, Lynn Luong, et al.
Molecular Reproduction and Development|December 29, 2007
Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockoutsRobert P Erickson, Wen Cao, Diana K Acuña, et al.
Bioorganic & Medicinal Chemistry|December 9, 2008
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2Angela J Russell, Isaac M Westwood, Matthew H J Crawford, et al.
Pageof 10